- Home
- LUCD vs LWLG Comparison
LUCD vs LWLG Comparison
Compare LUCD & LWLG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LUCD
- LWLG
- Stock Information
- Founded
- LUCD 2018
- LWLG 1991
- Country
- LUCD United States
- LWLG United States
- Employees
- LUCD N/A
- LWLG N/A
- Industry
- LUCD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- LWLG Containers/Packaging
- Sector
- LUCD Health Care
- LWLG Industrials
- Exchange
- LUCD Nasdaq
- LWLG Nasdaq
- Market Cap
- LUCD 140.7M
- LWLG 126.0M
- IPO Year
- LUCD 2021
- LWLG N/A
- Fundamental
- Price
- LUCD $1.26
- LWLG $1.22
- Analyst Decision
- LUCD Strong Buy
- LWLG
- Analyst Count
- LUCD 4
- LWLG 0
- Target Price
- LUCD $3.94
- LWLG N/A
- AVG Volume (30 Days)
- LUCD 1.2M
- LWLG 1.0M
- Earning Date
- LUCD 08-11-2025
- LWLG 08-08-2025
- Dividend Yield
- LUCD N/A
- LWLG N/A
- EPS Growth
- LUCD N/A
- LWLG N/A
- EPS
- LUCD N/A
- LWLG N/A
- Revenue
- LUCD $4,173,000.00
- LWLG $88,105.00
- Revenue This Year
- LUCD $91.46
- LWLG N/A
- Revenue Next Year
- LUCD $213.42
- LWLG N/A
- P/E Ratio
- LUCD N/A
- LWLG N/A
- Revenue Growth
- LUCD 39.89
- LWLG 24.23
- 52 Week Low
- LUCD $0.68
- LWLG $0.79
- 52 Week High
- LUCD $1.80
- LWLG $4.23
- Technical
- Relative Strength Index (RSI)
- LUCD 46.57
- LWLG 54.57
- Support Level
- LUCD $1.21
- LWLG $1.21
- Resistance Level
- LUCD $1.34
- LWLG $1.36
- Average True Range (ATR)
- LUCD 0.08
- LWLG 0.12
- MACD
- LUCD -0.01
- LWLG 0.01
- Stochastic Oscillator
- LUCD 50.00
- LWLG 59.18
About LUCD Lucid Diagnostics Inc.
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.
About LWLG Lightwave Logic Inc.
Lightwave Logic Inc is a United States-based development stage company moving toward commercialization of next-generation electro-optic photonic devices made on its P2IC technology platform which uses in-house proprietary high-activity and high-stability organic polymers. Electro-optical devices convert data from electric signals into optical signals for multiple applications. It designs and synthesizes organic chromophores for use in its own proprietary electro-optic polymer systems and photonic device designs.